PS
Piper Sandler Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
51
Analog Devices
ADI
$122B
|
HK
Harsh Kumar
| $247.07 | $245 |
1%
downside
| Neutral | 15 days ago |
|
52
Lowe's Companies
LOW
$151B
|
PK
Peter Keith
| $269.97 | $294 |
9%
upside
| Overweight | 15 days ago |
|
|
NESR
53
National Energy Services Reunited Corp. Ordinary Shares
NESR
$952M
|
DP
Derek Podhaizer
| $9.53 | $13 |
36%
upside
| Overweight | 15 days ago |
|
54
Central Pacific Financial
CPF
$841M
|
MC
Matthew Clark
| $31.16 | $35 |
12%
upside
| Overweight | 15 days ago |
|
55
First Hawaiian
FHB
$3.21B
|
MC
Matthew Clark
| $25.73 | $26 |
1%
upside
| Neutral | 15 days ago |
|
56
Bank of Hawaii
BOH
$2.72B
|
MC
Matthew Clark
| $68.31 | $71 |
4%
upside
| Neutral | 15 days ago |
|
57
ProFrac Holding
ACDC
$687M
|
DP
Derek Podhaizer
| $3.84 | $6 |
56%
upside
| Neutral | 16 days ago |
|
|
SEI
58
Solaris Energy Infrastructure, Inc.
SEI
$1.18B
|
DP
Derek Podhaizer
| $26.45 | $50 |
89%
upside
| Overweight | 16 days ago |
|
59
Vita Coco
COCO
$2.19B
|
ML
Michael Lavery
| $38.54 | $39 |
1%
upside
| Overweight | 16 days ago |
|
60
Ollie's Bargain Outlet
OLLI
$8.18B
|
PK
Peter Keith
| $133.40 | $150 |
12%
upside
| Overweight | 17 days ago |
|
61
Summit Therapeutics
SMMT
$19.3B
|
KG
Kelsey Goodwin
| $25.98 | $21 |
19%
downside
| Neutral | 17 days ago |
|
62
Ormat Technologies
ORA
$5.51B
|
DP
Derek Podhaizer
| $91.10 | $90 |
1%
downside
| Neutral | 17 days ago |
|
63
Janux Therapeutics
JANX
$1.44B
|
KG
Kelsey Goodwin
| $23.98 | $42 |
75%
upside
| Overweight | 17 days ago |
|
64
Revolution Medicines
RVMD
$7.57B
|
KG
Kelsey Goodwin
| $40.50 | $75 |
85%
upside
| Overweight | 17 days ago |
|
65
UroGen Pharma
URGN
$873M
|
KG
Kelsey Goodwin
| $18.88 | $36 |
91%
upside
| Overweight | 17 days ago |
|
66
CG Oncology
CGON
$2.52B
|
KG
Kelsey Goodwin
| $33.07 | $55 |
66%
upside
| Overweight | 17 days ago |
|
67
Tango Therapeutics
TNGX
$772M
|
KG
Kelsey Goodwin
| $6.94 | $11 |
59%
upside
| Overweight | 17 days ago |
|
68
Nuvalent
NUVL
$5.83B
|
KG
Kelsey Goodwin
| $80.89 | $112 |
38%
upside
| Overweight | 17 days ago |
|
|
BCAX
69
Bicara Therapeutics Inc. Common Stock
BCAX
$658M
|
KG
Kelsey Goodwin
| $12.06 | $36 |
199%
upside
| Overweight | 17 days ago |
|
70
Riskified
RSKD
$726M
|
CJ
Clarke Jeffries
| $4.63 | $6 |
30%
upside
| Overweight | 18 days ago |
|
71
TotalEnergies
TTE
$133B
|
RT
Ryan Todd
| $60.95 | $68 |
12%
upside
| Neutral | 18 days ago |
|
72
Shell
SHEL
$208B
|
RT
Ryan Todd
| $71.60 | $82 |
15%
upside
| Overweight | 18 days ago |
|
73
Exxon Mobil
XOM
$466B
|
RT
Ryan Todd
| $109.23 | $145 |
33%
upside
| Overweight | 18 days ago |
|
74
ConocoPhillips
COP
$116B
|
RT
Ryan Todd
| $92.95 | $124 |
33%
upside
| Overweight | 18 days ago |
|
75
Chevron
CVX
$310B
|
RT
Ryan Todd
| $153.66 | $168 |
9%
upside
| Overweight | 18 days ago |
|